Live feed07:00:00·5mPRReleasevia QuantisnowArmata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02ByQuantisnow·Wall Street's wire, on your screen.ARMP· Armata Pharmaceuticals Inc.Health Care
